(IMAX) Imax - Ratings and Ratios
Large Screens, Film Distribution, Audio Technology, Systems, Cameras
IMAX EPS (Earnings per Share)
IMAX Revenue
Description: IMAX Imax August 13, 2025
Imax Corp, listed on the NYSE under the ticker symbol IMAX, is a Canadian company operating in the Movies & Entertainment sub-industry. The companys stock is characterized by its volatility, as reflected in its beta of 0.812, indicating that it is less volatile than the overall market.
Key economic drivers for Imax Corp include the demand for premium cinema experiences, the growth of the global box office, and the adoption of its proprietary technology by cinemas worldwide. The companys revenue is largely dependent on box office performance, as well as the number of its screens installed globally. As a result, KPIs such as the number of screens installed, revenue per screen, and box office growth are crucial in evaluating the companys performance.
From a valuation perspective, Imax Corp has a market capitalization of $1.35 billion and a forward P/E ratio of 20.16, suggesting that the market expects earnings growth in the future. The companys return on equity (RoE) stands at 10.85%, indicating a relatively healthy profitability level. However, the high P/E ratio of 41.98 based on current earnings suggests that the stock may be overvalued if earnings do not meet expectations.
Technical analysis indicates that the stock is currently trading near its resistance levels, with the nearest resistance at $25.6 and $26.7. Support levels are identified at $24.3, $20.7, $16.9, and $15.8, providing potential downside protection. The Average True Range (ATR) of 0.79, equivalent to 3.11%, suggests moderate volatility, which may impact trading strategies.
IMAX Stock Overview
| Market Cap in USD | 1,745m |
| Sub-Industry | Movies & Entertainment |
| IPO / Inception | 1994-06-09 |
IMAX Stock Ratings
| Growth Rating | 78.5% |
| Fundamental | 71.3% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 11.1% |
| Analyst Rating | 4.36 of 5 |
IMAX Dividends
Currently no dividends paidIMAX Growth Ratios
| Growth Correlation 3m | 76% |
| Growth Correlation 12m | 73.3% |
| Growth Correlation 5y | 43.2% |
| CAGR 5y | 33.65% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.94 |
| CAGR/Mean DD 3y (Pain Ratio) | 3.01 |
| Sharpe Ratio 12m | 1.94 |
| Alpha | 37.08 |
| Beta | 0.613 |
| Volatility | 31.41% |
| Current Volume | 1522.4k |
| Average Volume 20d | 1060.7k |
| Stop Loss | 31.2 (-4.4%) |
| Signal | 0.59 |
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income (39.5m TTM) > 0 and > 6% of Revenue (6% = 22.6m TTM) |
| FCFTA 0.10 (>2.0%) and ΔFCFTA 8.07pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 40.66% (prev 66.66%; Δ -26.00pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.12 (>3.0%) and CFO 109.2m > Net Income 39.5m (YES >=105%, WARN >=100%) |
| Net Debt (114.1m) to EBITDA (105.4m) ratio: 1.08 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.84 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (55.6m) change vs 12m ago 2.73% (target <= -2.0% for YES) |
| Gross Margin 58.84% (prev 53.69%; Δ 5.15pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 43.43% (prev 40.77%; Δ 2.65pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 9.97 (EBITDA TTM 105.4m / Interest Expense TTM 7.18m) >= 6 (WARN >= 3) |
Altman Z'' 1.18
| (A) 0.17 = (Total Current Assets 336.5m - Total Current Liabilities 183.1m) / Total Assets 889.6m |
| (B) -0.27 = Retained Earnings (Balance) -240.6m / Total Assets 889.6m |
| (C) 0.08 = EBIT TTM 71.5m / Avg Total Assets 868.6m |
| (D) 0.36 = Book Value of Equity 163.3m / Total Liabilities 452.9m |
| Total Rating: 1.18 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 71.28
| 1. Piotroski 7.50pt = 2.50 |
| 2. FCF Yield 4.93% = 2.46 |
| 3. FCF Margin 24.27% = 6.07 |
| 4. Debt/Equity 0.74 = 2.24 |
| 5. Debt/Ebitda 1.08 = 1.65 |
| 6. ROIC - WACC (= 2.73)% = 3.41 |
| 7. RoE 12.47% = 1.04 |
| 8. Rev. Trend 3.32% = 0.25 |
| 9. EPS Trend 33.33% = 1.67 |
What is the price of IMAX shares?
Over the past week, the price has changed by +1.27%, over one month by -3.18%, over three months by +28.72% and over the past year by +34.89%.
Is Imax a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IMAX is around 34.53 USD . This means that IMAX is currently overvalued and has a potential downside of 5.82%.
Is IMAX a buy, sell or hold?
- Strong Buy: 7
- Buy: 2
- Hold: 1
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the IMAX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 37.2 | 13.9% |
| Analysts Target Price | 37.2 | 13.9% |
| ValueRay Target Price | 38.1 | 16.7% |
IMAX Fundamental Data Overview November 01, 2025
P/E Trailing = 45.6761
P/E Forward = 22.2717
P/S = 4.6196
P/B = 5.5375
P/EG = 0.8895
Beta = 0.613
Revenue TTM = 377.2m USD
EBIT TTM = 71.5m USD
EBITDA TTM = 105.4m USD
Long Term Debt = 229.9m USD (from longTermDebt, last fiscal year)
Short Term Debt = 230.7m USD (from shortTermDebt, last quarter)
Debt = 257.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 114.1m USD (from netDebt column, last quarter)
Enterprise Value = 1.86b USD (1.74b + Debt 257.2m - CCE 143.1m)
Interest Coverage Ratio = 9.97 (Ebit TTM 71.5m / Interest Expense TTM 7.18m)
FCF Yield = 4.93% (FCF TTM 91.6m / Enterprise Value 1.86b)
FCF Margin = 24.27% (FCF TTM 91.6m / Revenue TTM 377.2m)
Net Margin = 10.48% (Net Income TTM 39.5m / Revenue TTM 377.2m)
Gross Margin = 58.84% ((Revenue TTM 377.2m - Cost of Revenue TTM 155.3m) / Revenue TTM)
Gross Margin QoQ = 62.90% (prev 58.46%)
Tobins Q-Ratio = 2.09 (Enterprise Value 1.86b / Total Assets 889.6m)
Interest Expense / Debt = 0.71% (Interest Expense 1.83m / Debt 257.2m)
Taxrate = 18.71% (5.21m / 27.8m)
NOPAT = 58.2m (EBIT 71.5m * (1 - 18.71%))
Current Ratio = 1.84 (Total Current Assets 336.5m / Total Current Liabilities 183.1m)
Debt / Equity = 0.74 (Debt 257.2m / totalStockholderEquity, last quarter 349.5m)
Debt / EBITDA = 1.08 (Net Debt 114.1m / EBITDA 105.4m)
Debt / FCF = 1.25 (Net Debt 114.1m / FCF TTM 91.6m)
Total Stockholder Equity = 317.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.45% (Net Income 39.5m / Total Assets 889.6m)
RoE = 12.47% (Net Income TTM 39.5m / Total Stockholder Equity 317.2m)
RoCE = 13.08% (EBIT 71.5m / Capital Employed (Equity 317.2m + L.T.Debt 229.9m))
RoIC = 10.01% (NOPAT 58.2m / Invested Capital 581.1m)
WACC = 7.28% (E(1.74b)/V(2.00b) * Re(8.27%) + D(257.2m)/V(2.00b) * Rd(0.71%) * (1-Tc(0.19)))
Discount Rate = 8.27% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.53%
[DCF Debug] Terminal Value 69.45% ; FCFE base≈62.5m ; Y1≈41.0m ; Y5≈18.8m
Fair Price DCF = 6.59 (DCF Value 354.8m / Shares Outstanding 53.8m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 33.33 | EPS CAGR: 39.01% | SUE: 3.01 | # QB: 2
Revenue Correlation: 3.32 | Revenue CAGR: 2.93% | SUE: 0.07 | # QB: 0
Additional Sources for IMAX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle